On Friday, Core Laboratories Inc (NYSE: CLB) opened lower -3.75% from the last session, before settling in for the closing price of $10.94. Price fluctuations for CLB have ranged from $10.14 to $24.45 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the drop rate of yearbook sales for the company of the Energy sector was -20.53%. Company’s average yearly earnings per share was noted -18.70% at the time writing. With a float of $46.37 million, this company’s outstanding shares have now reached $46.54 million.
Considering the fact that the conglomerate employs 3500 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 16.71%, operating margin of 10.38%, and the pretax margin is 8.24%.
Core Laboratories Inc (CLB) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Oil & Gas Equipment & Services industry is another important factor to consider. The insider ownership of Core Laboratories Inc is 1.12%, while institutional ownership is 110.66%.
Core Laboratories Inc (CLB) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.19 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -18.70% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 2.03% during the next five years compared to -20.53% drop over the previous five years of trading.
Core Laboratories Inc (NYSE: CLB) Trading Performance Indicators
Check out the current performance indicators for Core Laboratories Inc (CLB). In the past quarter, the stock posted a quick ratio of 1.70. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.95. Likewise, its price to free cash flow for the trailing twelve months is 12.59.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.62, a number that is poised to hit 0.21 in the next quarter and is forecasted to reach 0.80 in one year’s time.
Technical Analysis of Core Laboratories Inc (CLB)
Compared to the last year’s volume of 0.46 million, its volume of 0.48 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 4.41%.
During the past 100 days, Core Laboratories Inc’s (CLB) raw stochastic average was set at 6.67%, which indicates a significant decrease from 7.65% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.70 in the past 14 days, which was higher than the 0.64 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.76, while its 200-day Moving Average is $15.38. Nevertheless, the first resistance level for the watch stands at $10.78 in the near term. At $11.03, the stock is likely to face the second major resistance level. The third major resistance level sits at $11.29. If the price goes on to break the first support level at $10.27, it is likely to go to the next support level at $10.01. Now, if the price goes above the second support level, the third support stands at $9.76.
Core Laboratories Inc (NYSE: CLB) Key Stats
There are currently 46,894K shares outstanding in the company with a market cap of 493.79 million. Presently, the company’s annual sales total 523,850 K according to its annual income of 31,400 K. Last quarter, the company’s sales amounted to 130,160 K and its income totaled 10,640 K.
